Official Presentation of SOLACI / SIAC Latin American Clinical TAVR Guidelines

The Latin American Society of Interventional Cardiology (SOLACI) and the Inter-American Society of Cardiology (SIAC) have jointly developed their Clinical Guidelines on Transcatheter Aortic Valve Replacement (TAVR) to be presented this week at the Virtual SIAC Congress. 

The creation of these guidelines is the result of an important joint effort between SOLACI and SIAC during these past 18 months. It aims at establishing a series of recommendations and therapeutic behaviors based on a systematic revision of the existing evidence, to improve and optimize TAVR practice across Latin America (and therefore improve patient care). 

All the information collected in this joint work is supported by robust international quality standards that guarantee absolute trust and transparency.  

The presentation will be held online, on Wednesday, June 6, 2021, at 04 PM (Panama time) at the virtual SIAC, and will be delivered by Dr. Pablo Lamelas (Argentina), SOLACI Research Director. Doctors Alfaro Marchena (Panama), Luis gutiérrez Jaikel (Costa Rica), José Edgar Villegas (Colombia), Mónica Giambruno (Uruguay), Magalí Arrais (Brasil), Oscar Paredes (Paraguay) and Carla Agatiello (Argentina) will also take part.

Looking forward to seeing you at SIAC virtual Congress for this important release!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....